Evidence map›Paper›PMID 37789455›Full record

ArticleBiological research2023

Focal ischemic stroke modifies microglia-derived exosomal miRNAs: potential role of mir-212-5p in neuronal protection and functional recovery.

Si-Si Li, Jia-Jia Wu, Xiang-Xin Xing, Yu-Lin Li, Jie Ma, Yu-Jie Duan, Jun-Peng Zhang, Chun-Lei Shan, Xu-Yun Hua, Mou-Xiong Zheng and 1 more

Abstract read
In one paragraph

Article in Biological research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Si-Si Li *School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China.
Jia-Jia Wu *Center of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Xiang-Xin Xing *Center of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Yu-Lin LiSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China.
Jie MaCenter of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
Yu-Jie DuanSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China.
Jun-Peng ZhangSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China.
Chun-Lei ShanSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China.
Xu-Yun HuaDepartment of Traumatology and Orthopedics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China. huaxuyun@shutcm.edu.cn.
Mou-Xiong ZhengDepartment of Traumatology and Orthopedics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China. zhengmouxiong@shutcm.edu.cn.
Jian-Guang XuSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, NO. 1200, Cailun Road, Shanghai, 201203, Shanghai, China. xjg@shutcm.edu.cn.

Funding

National Natural Science Foundation of China 81802249National Natural Science Foundation of China 81871836National Natural Science Foundation of China 81874035National Natural Science Foundation of China 81902301Program of Shanghai Academic Research Leader 19XD1403600Shanghai Municipal Commission of Health and Family Planning 2018YQ02, and 201840224Shanghai Rising-Star Program 19QA1409000Shanghai Science and Technology Committee 18511108300, 18441903900, and 18441903800Shanghai Youth Top Talent Development Plan and Shanghai Rising Stars of Medical Talent Youth Development Program RY411.19.01.10the National Key R&D Program of China 2018YFC2001600, and 2018YFC2001604
6 · The paper itself

Abstract

backgroundIschemic stroke is a severe type of stroke with high disability and mortality rates. In recent years, microglial exosome-derived miRNAs have been shown to be promising candidates for the treatment of ischemic brain injury and exert neuroprotective effects. Mechanisms underlying miRNA dysregulation in ischemic stroke are still being explored. Here, we aimed to verify whether miRNAs derived from exosomes exert effects on functional recovery.

methodsMiR-212-5p agomir was employed to upregulate miR-212-5p expression in a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) as well as an oxygen-glucose deprivation/reoxygenation (OGD/R) in vitro. Western blot analysis, qRT-PCR and immunofluorescence staining and other methods were applied to explore the underlying mechanisms of action of miR-212-5p.

resultsThe results of our study found that intervention with miR-212-5p agomir effectively decreased infarct volume and restored motor function in MCAO/R rats. Mechanistically, miR-212-5p agomir significantly reduced the expression of PlexinA2 (PLXNA2). Additionally, the results obtained in vitro were similar to those achieved in vivo.

conclusionIn conclusion, the present study indicated that PLXNA2 may be a target gene of miR-212-5p, and miR-212-5p has great potential as a target for the treatment and diagnosis of ischemic stroke.

Indexed as

Infarction, Middle Cerebral ArteryIschemic StrokeMicroRNAsAnimalsApoptosisMicrogliaNeuroprotectionRatsReperfusion InjuryMicroRNAsMIRN212 microRNA, ratExosomalIschemic strokeMicroglialMiR-212-5pNeuronal protectionPlexinA2

Identifiers

PMID37789455
PMCPMC10548705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.